COM
BIOMARIN PHARMACEUTICAL INC
BIOMARIN PHARMACEUTICAL INC
Holdings as of 2023-12-31Filed 2024-02-14Updated 2026-10-22
View original evidence ↗Viewing holdings for 2023 Q4. View latest quarter →
Investors holding3
New positions2
Increased1
Decreased0
Exited0
Holdings by investor
↓ CSV↔ Scroll table
| Investor | Portfolio weight | Shares | Shares Δ | Change | Filed | Evidence |
|---|---|---|---|---|---|---|
| Elliott Investment ManagementElliott Investment Management | 3.50%+3.5 pp | 3,000,338 | — | New | 2024-02-14 | SEC filing |
| Viking GlobalViking Global | 1.73%+0.2 pp | 4,889,454 | +16.0% | Increased | 2024-02-14 | SEC filing |
| Daniel LoebThird Point | 0.56%+0.6 pp | 385,000 | — | New | 2024-02-14 | SEC filing |
Ownership over time
All 20 quarters
| Quarter | Investors holding |
|---|---|
| 2026 Q2 | 1 |
| 2026 Q1 | 1 |
| 2025 Q4 | 1 |
| 2025 Q3 | 1 |
| 2025 Q2 | 1 |
| 2025 Q1 | 2 |
| 2024 Q4 | 2 |
| 2024 Q3 | 2 |
| 2024 Q2 | 3 |
| 2024 Q1 | 3 |
| 2023 Q4 | 3 |
| 2023 Q3 | 1 |
| 2023 Q2 | 1 |
| 2023 Q1 | 1 |
| 2022 Q4 | 1 |
| 2022 Q3 | 1 |
| 2022 Q2 | 1 |
| 2022 Q1 | 1 |
| 2021 Q4 | 1 |
| 2021 Q3 | 0 |
Original sources
Public commentary is shown only when a dated, verified original is available.
Third PointOfficial SEC filing
Viking GlobalOfficial SEC filing
Elliott Investment ManagementOfficial SEC filing
Advanced · SEC data & downloads
CUSIP 09061G101 · COM
Original information table · XML/data
Original information table · XML/data
Original information table · XML/data
Elliott Investment Management · 13F-HR · SEC filing · TXT
Viking Global · 13F-HR · SEC filing · TXT
Third Point · 13F-HR · SEC filing · TXT
Download full history CSV · all candidate groups